Last reviewed · How we verify

NCT04578080

Effect of tDCS on Motor Functions and Brain Activity in Acute Stroke Patients

Completed NA Last updated 22 June 2022
What this trial tests

NA trial testing Transcranial direct current stimulation in Stroke, Acute in 30 participants. Completed in 1 June 2022.

Timeline
1 October 2020
Primary endpoint
1 June 2022
1 June 2022

Quick facts

Lead sponsorMahidol University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingtriple
Primary purposetreatment
Enrollment30
Start date1 October 2020
Primary completion1 June 2022
Estimated completion1 June 2022
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Mahidol University

Who can join

Adults 18 to 75, any sex, with Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effects of anodal tDCS combined with conventional physical therapy for 5 consecutive sessions on motor functions and brain activity in acute stroke patients at immediate and 1-month follow-up.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of anodal tDCS on resting state eeg power and motor function in acute stroke: a randomized controlled trial.
    Vimolratana O, Aneksan B, Siripornpanich V, Hiengkaew V, et al · · 2024 · cited 13× · PMID 38172973 · DOI 10.1186/s12984-023-01300-x

Verify or expand the search:

Other trials of Transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Stroke, Acute

Currently open trials in the same condition.

Other Mahidol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04578080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing